A Double-blind, Randomized, Active-controlled, Parallel-group Study of Paliperidone Palmitate 6-Month Formulation
Research payments
$1,953,682
Through program year 2020, $1,953,682 in research payments was reported against A Double-blind, Randomized, Active-controlled, Parallel-group Study of Paliperidone Palmitate 6-Month Formulation, across 379 payments, paid by Janssen Research & Development, LLC.
- Paid by
- Janssen Research & Development, LLC
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $192,223 | 87 |
| 2019 | Research | $1,761,459 | 292 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jianping Zhang Glen Oaks, NY Named on 26 payments
- Constantin Abuzatoaie Hoffman Estates, IL Named on 25 payments
- Manuel Fernandez-Gonzalez Miami, FL Named on 25 payments
- Michael Downing Dallas, TX Named on 24 payments
- Thomas Lester Orange, CA Named on 24 payments
- Daniel Gruener Philadelphia, PA Named on 23 payments
- Subhdeep Virk Buffalo, NY Named on 21 payments
- Robert Riesenberg Atlanta, GA Named on 21 payments
- Otto Dueno Dayton, OH Named on 21 payments
- Robert Billingsley Fayetteville, AR Named on 17 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.